On August 27, 2026, 汇添富基金管理股份有限公司 sold 48,000 shares of KEYMED BIO-B at an average of HKD 78.401 per share, involving about HKD 3.76 million.
Prior to the disposal, the declarant's long position in KEYMED BIO-B was 14.94 million shares, representing 5.0%; following the disposal, the holding changed to 14.89 million shares, with the long position ratio falling to 4.98%.